GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzolytics Inc (OTCPK:ENZC) » Definitions » EPS (Diluted)

Enzolytics (Enzolytics) EPS (Diluted) : $-170.27 (TTM As of Jun. 2011)


View and export this data going back to 2008. Start your Free Trial

What is Enzolytics EPS (Diluted)?

Enzolytics's Earnings per Share (Diluted) for the three months ended in Jun. 2011 was $-5.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2011 was $-170.27.

Enzolytics's EPS (Basic) for the three months ended in Jun. 2011 was $-5.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2011 was $-170.27.

Enzolytics's EPS without NRI for the three months ended in Jun. 2011 was $-5.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2011 was $-145.40.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Enzolytics EPS (Diluted) Historical Data

The historical data trend for Enzolytics's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzolytics EPS (Diluted) Chart

Enzolytics Annual Data
Trend Dec07 Jul08 Dec09 Dec10
EPS (Diluted)
- -176.97 -255.00 -540.00

Enzolytics Quarterly Data
Sep07 Dec07 Apr08 Jul08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -140.00 -55.00 -105.27 -5.00 -5.00

Competitive Comparison of Enzolytics's EPS (Diluted)

For the Biotechnology subindustry, Enzolytics's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzolytics's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enzolytics's PE Ratio distribution charts can be found below:

* The bar in red indicates where Enzolytics's PE Ratio falls into.



Enzolytics EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Enzolytics's Diluted EPS for the fiscal year that ended in Dec. 2010 is calculated as

Diluted EPS (A: Dec. 2010 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-7.514-0)/0.014
=-536.71

Enzolytics's Diluted EPS for the quarter that ended in Jun. 2011 is calculated as

Diluted EPS (Q: Jun. 2011 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.221-0)/0.039
=-5.67

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-170.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enzolytics  (OTCPK:ENZC) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Enzolytics EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Enzolytics's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzolytics (Enzolytics) Business Description

Traded in Other Exchanges
N/A
Address
1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013
Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies, and an artificial intelligence (AI) platform for health care developments. It has clinically tested anti-HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.

Enzolytics (Enzolytics) Headlines

From GuruFocus